Key facts
- It has raised $11.4M; the latest was Early Stage VC ($9.0M) in Nov 2025.
- Notable investors include Alumni Ventures, Google for Startups, Tiny Supercomputer Investment Company, Labcorp Venture Fund, Wormhole Capital — 18 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 18 names
- ·Watchlist + deal alerts for Emm
- ·The full record, as it builds
Funding rounds
No funding rounds for Emm are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Emm
Developer of a biowearable menstrual device designed to provide a deeper understanding of the menstrual cycle and overall health. The company offers ultra-thin sensor technology combined with medical-grade silicone, enabling women seeking better health insights, early detection, and improved care to gain meaningful, data-driven awareness of their bodies.
- Sector
- Healthcare
- HQ
- Bristol, United Kingdom
- Founded
- 2020
- Employees
- 38
- Website
- emm.co/
- Ownership
- Privately Held (backing)
Emm doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Emm shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Emm in its N-PORT filings yet. We sweep new filings monthly.